Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-24 Sale | 2023-03-28 5:00 pm | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks | 300 | $69.92 | $20,977 | 16,308 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-27 Option Award | 2024-02-29 6:50 pm | N/A 2034-02-27 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & | 36,480 | $0 | 51,477 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 8:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & | 593 | $74.65 | 14,997 (Direct) | View |
| 2023-12-29 Other | 2024-01-04 4:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & | 179 | $60.71 | 15,769 (Direct) | View |
| 2023-08-10 Tax Withholding | 2023-08-14 4:20 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew CHIEF LEGAL OFFICER & | 897 | $68.73 | 15,411 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 8:51 pm | N/A 2033-02-23 | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks | 21,061 | $0 | 32,001 (Direct) | View |
| 2022-11-30 Tax Withholding | 2022-12-01 9:39 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks | 1,073 | $72.9 | 10,940 (Direct) | View |
Ownership | 2022-11-07 8:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks | 0 | $0 | 84,957 (Direct) | View |